20260122_MMIX_Laporan Informasi dan Fakta Material_32021769_lamp2.pdf

MMIX management also confirmed its commitment in maintaining the profitability
momentum until the end of fiscal year 2025 through sustainable cost control without
reducing quality, focussing on products with healthy margins, efficient distribution, and
strict inventory management. The year 2025 is positioned as a year of fundamental
recovery, with sustainable profit targets and increasingly healthy margins through a
prudent approach.
Entering 2026, MMIX sets the business direction by placing the baby care segment as
the main growth engine, accompanied by selective product diversification in the personal
care and adult care categories. The company targets controlled and quality growth, in line
with the dynamics of the Indonesian FMCG market which is projected to grow 6-9% YoY
in 2026, with the Baby & Child Care segment expected to grow 8–11% YoY to USD 1,8
Billion and Personal Care & Beauty by 9–12% YoY. to USD 2,5 Billion
The contribution of the Mom & Baby segment is projected to remain dominant, which is
around 40–50% of MMIX's total revenue in 2026, supported by the increase in the
productivity of baby and adult diaper factories. On the other hand, the line of wet wipes
and hygiene products is estimated to contribute 15–20% to the 2026 revenue, along
with the increase in consumer awareness of hygiene products and daily needs.
Looking at the shift in consumer behaviour reflected in the sales data for the 2023-2025
period, MMIX assesses that consumers, especially the Gen Z and Alpha generations, are
increasingly acting as smart buyers with wide and independent access to information.
Consumers become more rational and value-oriented, with an increased preference for
practical and multifunctional products. Packaging flexibility, both in the form of small packs
and value packs, is becoming increasingly relevant to answer these needs. On the other
hand, the dominance of digital channels and the omnichannel approach strengthens the
change in shopping patterns, encouraging MMIX to adjust the 2026 FMCG product
strategy to be more adaptive, transparent, and in line with the behaviour of consumers
who are increasingly intelligent and informative.
In the medium to long term, MMIX targets business transformation into a manufacturing
and brand-based FMCG company, with a revenue growth of 10–15% per year in the
period 2026–2030. The revenue structure will be made more balanced between the mom
& baby, hygiene, and beauty care segments, with a focus on product differentiation, local
manufacturing efficiency, and strengthening profitability and cash flow.
"The main difference between house brand and private label lies in the level of control
and strategic direction of product development. In house brands, companies have full
control over innovation, quality, positioning, and long-term brand management, while
private labels are more focussed on fulfilling the needs of retail partners with certain
specifications," explained Mengky Mangarek.

Mengky Mangarek said that private labels in Indonesia still have significant growth room
in the future, along with the increasing rationality of value-oriented consumers and
openness to product alternatives with competitive quality. However, the growth will be
greatly determined by quality consistency, cost efficiency, and the ability of manufacturing
partners to maintain product standards sustainably.
Through this presentation at CNBC Closing Bell, MMIX emphasises the business
direction of 2026 which is built on solid fundamentals, measurable growth strategies, and
a strong commitment to quality and value for consumers.


About PT Multi Medika International Tbk :
PT Multi Medika Internasional Tbk (MMI) is a leading company in Indonesia engaged in
the Fast-Moving Consumer Goods (FMCG) sector. Established since 2020, PT MMI has
been committed to providing high quality products that fulfil the daily needs of the
community. With the main focus on innovation and customer satisfaction, the Company
offers various superior products such as bamboo wipes, baby diapers, and alkaline water
with high pH.
In addition, MMI is also actively expanding its distribution network throughout Indonesia
through strategic partnerships with various leading stores and distributors. Through this
effort, MMI continues to strengthen its position in the market and contributes to improving
the quality of life of consumers in various regions.
With the vision of becoming a leader in the FMCG industry, MMI is always innovating and
adaptive to changing market needs, and is committed to providing added value for
shareholders and the wider community.
For more information:
Corporate Secretary
PT Multi Medika Internasional Tbk,
SOHO CAPITAL, Podomoro City Land
32th Floor, Suite 3205A
Letjen S. Parman St. No. Kav 28, Jakarta Barat, Indonesia
Office        : +62815-1919-8888
Email         : corpsec@multimed.co.id
Website       : https://www.multimed.co.id/